Pediatric Brain Cancer Impact Grant

Kids need to do more than survive brain cancer. They deserve to thrive.

2017 Update: Dr Taylor and his team have now identified 12 subtypes of medulloblastoma. They have also discovered that each subtype is completely different at the time of recurrence, so another resection is needed to determine the new type. This also means that a new treatment might be necessary for the new subtype. Dr Taylor and his team continue to work on what those treatment types should be. More to come... In the meantime, you can read the full report here.

We still need more help raising funds to enable this project to be completed. Your investment will be matched dollar for dollar, so please give generously!
2016 Update: Dr. Taylor and his team have now completed the first year of this five year research project. And we have received the first report, which you can read here! 

It’s time for exceptional change in the progress of brain cancer research.

Because of kids’ growing brains and bodies, chemotherapy and radiation are detrimental to their ongoing development. Those who do survive a brain cancer diagnosis are often left with devastating side effects that change their lives forever.

What happens to a child after they are treated for Brain Cancer? 

Children treated with chemotherapy or radiation are eight times more likely to develop severe health problems, especially as they age into their 20s and 30s. The higher the dose of drugs and the more extensive the radiation, the more problems are to emerge. The impact of brain cancer treatments can include: blindness, fertility issues, hearing loss, learning and emotional disabilities, memory deficits, stunted puberty or hormone problems, the list goes on.

The Solution: Personalized Brain Cancer Treatment

Medulloblastoma is the most common childhood brain cancer.

Renowned researcher, Dr. Michael Taylor, was the first to discover that medulloblastoma wasn’t just one form of brain cancer, but four distinct types — each with their own DNA footprint, and therefore potential treatment needs. Thanks to the first year of research, we now know that there are at least ten different types. Read more...

Now Dr. Taylor and his team of researchers want to know how each type of medulloblastoma changes in response to treatment, and how to develop personalized care for every child diagnosed. This means the most aggressive treatments are only used on the most aggressive brain cancers, saving children from life-changing side effects or secondary diseases. 

Give today to the Pediatric Brain Cancer Impact Grant and your gift will be matched dollar-for-dollar. DONATE NOW!

About Dr. Michael Taylor

Brain Tumour Foundation of Canada Impact Grant recipient Dr Michael Taylor

Pediatric neurosurgeon and principal investigator at one of Canada’s leading brain tumour research centres

Has published ~100 medical publications and is a renowned international speaker 

Received a 2014 Brain Tumour Foundation of Canada Research Grant

Awarded the Schweizguth Prize from the International Society of Paediatric Oncology, Great Britain (2005)

Recipient of the National Cancer Institute of Canada Fellowship (1998)
 

Together, we are providing what every Canadian affected by a brain tumour needs, hope.

About the matching funds

Pediatric Brain Cancer Impact Grant Goal UpdateWhen you give to the Pediatric Brain Cancer Impact Grant, YOUR INVESTMENT DOUBLES IMMEDIATELY!

All donations made to this unique Impact Grant are matched, dollar for dollar, through our partnership with Brain Canada. Your lifesaving gift will double to propel childhood brain cancer research forward, even faster!
 

Donate now and change the future of childhood brain cancer.

Donate Online Today or contact:

Suzanne Fratschko Elliott
Fundraising and Engagement Manager
sfelliott@braintumour.ca
1-800-265-5106 or 519-642-7755, ext. 227 

 

Share This

Featured Story

Pablo's Story: The real blessing in all of this

In 2010, Pablo found himself in the ER eight times within six weeks. Intense headaches, drastic weight loss, jaundice, dizziness, and lapses in time were repeatedly dismissed by doctors, but Pablo knew that something was very wrong. Choosing to advocate for his health when others might have given up, Pablo sought out the opinion of his family practitioner and his persistence may have, in fact, saved his life. An MRI revealed a grade IV atypical meningioma on Pablo’s brain.

Learn more

Spotlight

Catarina's Story: Crush Cushing’s

Brain Tumour Walk events bring people together. People like Catarina and Danielle, both survivors of pituitary tumours that caused...

Learn more

Where our footsteps lead...

We remain inspired by the bravery and perseverance of the brain tumour community, including kids like 6-year-old Joshua, who completed...

Learn more

Upcoming Events

  • 26/Sep/2017: Groupe de soutien virtuel: Un groupe de soutien virtuel pour personnes touchées par une tumeur... Learn more >
  • 27/Sep/2017: Toronto Support Group: Meets at Wellspring Westerkirk House at Sunnybrook, Toronto, ON... Learn more >
  • 27/Sep/2017: Ottawa Support Group: Meets at the Maplesoft Centre at 1500 Alta Vista Drive, Ottawa, ON.... Learn more >
  • 28/Sep/2017: Virtual Support Group East: Virtual Support Group for Eastern Canada... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2017 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001
35 Years